The market is likely paying for a clean cyclical rebound plus cost discipline, but that combination is usually the point at which staffing multiple expansion becomes vulnerable. In this business, incremental revenue improvement converts fast to EPS on the way up, yet it also means any slowdown in hiring or client project activity hits sentiment disproportionately within 1-2 quarters. The operating leverage story is real, but it is not a moat: peers such as RHI, KELYA, and global rivals can mirror SG&A tightening quickly, so margin gains may prove transient rather than re-rating-worthy.

The bigger second-order issue is that staffing is an early-cycle indicator, not a late-cycle compounder. If labor demand softens even modestly, the stock can de-rate before fundamentals fully roll over because investors tend to front-run volume inflection, especially after a large run. That makes the current setup more interesting as a momentum exhaustion trade than a pure fundamental long; the capital return framework supports downside cushioning, but it does not change the fact that buybacks are typically highest just before the cycle cools.

Balance-sheet optics are better, but not transformative: the debt profile looks manageable, and the apparent improvement is partly timing/reclassification rather than true de-risking. The real catalyst path is the next 1-2 earnings prints and labor data; if cc growth holds above mid-single digits and SG&A remains down, the rally can extend, but if growth slips back toward low-single digits, the stock likely loses its premium quickly. Contrarian take: the move may already have discounted most of the easy recovery, while the risk-reward now favors a fade on any disappointment rather than chasing strength.